Author

R Pugh

Observed names: REGINALD E. PUGH, Reginald E. Pugh, Reginald Pugh

Observed institutions: Grand Rapids Community College, Allegheny Health Network, The University of Texas at San Antonio Health Science Center, Cancer Research Center, SWOG Cancer Research Network, University of Arizona Cancer Center

OpenAlex ID: A5110094888

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study

2000 · Richard M. Elledge, Stephanie Green, et al. · International Journal of Cancer · 329

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.

1997 · B Fisher, S Anderson, et al. · Journal of Clinical Oncology · 308

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.

1998 · R M Elledge, S Green, et al. · PubMed · 259

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.

1997 · R M Elledge, S Green, et al. · Journal of Clinical Oncology · 138

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.

1982 · M Al-Sarraf, W Fletcher, et al. · PubMed · 134

A southwest oncology group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer

1991 · Daniel D. Von Hoff, Richard Kronmal, et al. · Cancer · 66

Treatment of cancer with weekly intravenous 5-fluorouracil.Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG)

1971 · Edwin M. Jacobs, William J. Reeves, et al. · Cancer · 59

Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study).

1998 · D R Ciocca, S Green, et al. · PubMed · 43

Study of tamoxifen in metastatic renal cell carcinoma and the influence of certain prognostic factors: a Southwest Oncology Group Study.

1981 · M Al-Sarraf, H Eyre, et al. · PubMed · 23

Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer a randomized trial

1983 · Rowan T. Chlebowski, Reginald Pugh, et al. · Cancer · 8

A Southwest Oncology Group Study on the Use of a Human Tumor Cloning Assay for Predicting Response In Patients With Ovarian Cancer

1991 · DANIEL D. VON HOFF, RICHARD KRONMAL, et al. · Obstetrical & Gynecological Survey · 6

Doxorubicin and Methotrexate on a Weekly Schedule in Patients with Sarcomas

2009 · Rowan T. Chlebowski, Francis Bull, et al. · Oncology · 4

Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.

1980 · R M Bukowski, A LoBuglio, et al. · PubMed · 3

2009 · W.R. Bezwoda, A. Weaving, et al. · Oncology

Works count: 14

Citation count: 1,380

H-index: 9

I10-index: 9